Hervé Dombret

22PUBLICATIONS
197CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Aug 26, 2025
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.

Manon Delafoy, Mickaël F Bonnet, Etienne Lengliné

|Mar 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

David Fandrei, Jean Pegliasco, Florence Pasquier

|Oct 17, 2024
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Patrice Chevallier, Thibaut Leguay, Marc Delord

|Jul 19, 2024
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study.

Rathana Kim, Yves Chalandon, Philippe Rousselot

|Mar 07, 2024
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.

Yves Chalandon, Philippe Rousselot, Sylvie Chevret

Pageof 4

Frequent Collaborators

7 joint publications

Rathana Kim

7 joint publications

Raphaël Itzykson

7 joint publications

Nicolas Boissel

6 joint publications

Sylvain Chantepie